Atezolizumab in combination with cabozantinib is in clinical development for the treatment of advanced renal cell carcinoma (RCC) after prior treatment. RCC (also called kidney cancer) is a disease that affects the lining of tiny tubes within the kidney which filter waste from the blood, making urine. In many cases of RCC there are no […]
Nivolumab and ipilimumab is in development for the first-line treatment of advanced hepatocellular carcinoma (HCC). HCC is the most common type of primary liver cancer, which affects men more than women, and is more likely to develop the older a person gets. Advanced HCC means the cancer is incurable. Symptoms include weight loss, jaundice (yellowing […]
Otilimab in combination with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) is in clinical development for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response to conventional synthetic DMARDs and/or targeted therapies (biologic DMARDs and Janus Kinase inhibitors). RA is a chronic autoimmune condition where the […]
Neoadjuvant treatment of durvalumab in combination with gemcitabine-cisplatin and adjuvant treatment of durvalumab alone are currently in clinical development for patients with muscle-invasive bladder cancer (MIBC). Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. When the cancerous cells spread beyond the lining, into the surrounding […]
Niraparib with abiraterone acetate and prednisone (AAP) is in clinical development for patients with prostate cancer which has spread from its original site (metastatic) and is untreatable via testosterone suppression therapy (castration resistant). Prostate cancer is a cancer of the prostate gland (a small organ in a man’s pelvis) and is the most common cancer […]
Letermovir is in clinical development for adult patients who have received a kidney transplant and are at risk of developing cytomegalovirus disease (CMV). CMV is normally a mild infection that causes flu-like symptoms but can be life-threatening in certain groups. Once infected with CMV, the virus stays in the body throughout a person’s life with […]
Efanesoctocog alfa is currently in clinical development for the treatment and prevention (prophylaxis) of bleeding episodes in patients with haemophilia A. Haemophilia A is a genetic bleeding disorder caused by a deficiency or absence of a blood clotting factor, called factor VIII (eight). This causes poor blood clotting, which results in difficulty in stopping the […]
Cholangiocarcinoma is a rare type of cancer that affects the bile ducts. Different subtypes of cholangiocarcinoma are classified by the location at which they develop in the biliary tract. Genetic changes (mutations) to the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) plays a central role in development of cholangiocarcinoma by contributing to the growth of abnormal […]
Enzalutamide is currently in clinical development for the treatment of high-risk non-metastatic prostate cancer (cancer that has not spread beyond the prostate) that has been previously treated with a radical prostatectomy (surgery to remove the prostate gland) and/or radiotherapy. Prostate cancer develops in the prostate gland and is the most common cancer in men in […]
Nivolumab in combination with ipilimumab is in clinical development as adjuvant therapy for adult patients with localised renal cell carcinoma (RCC) who underwent partial or entire removal of a kidney. RCC (the most common type of kidney cancer in adults) is a disease that affects the lining of tiny tubes within the kidney which filter […]
Subscribe to new content email alerts
Email *
Interested groups * Achondroplasia Activated PI3K delta syndrome Acute hepatic porphyria (AHP) Acute lymphoblastic leukaemia (ALL) Acute myeloid leukaemia (AML) Adrenoleukodystrophy (ALD) Adrenomyeloneuropathy (AMN) Age-related macular degeneration (AMD) Alagille syndrome Alkaptonuria Alopecia areata Alport Syndrome Alzheimer's disease Amyloidosis Amyotrophic lateral sclerosis Anaemia Anaemia due to myelodysplastic syndromes (MDS) Anaemic myelofibrosis Anaesthesia Anal cancer Anaplastic large cell lymphoma (ALCL) Aneurysmal subarachnoid haemorrhage Angioimmunoblastic T-cell Lymphoma (AITL) Ankylosing spondylitis Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) Aromatic L-amino acid decarboxylase (AADC) deficiency Arterial venous access Articular cartilage defects Asthma Atopic dermatitis Atypical haemolytic uraemic syndrome (aHUS) Axial spondyloarthritis B-cell non-Hodgkin lymphoma Back pain Benign prostatic hyperplasia (BPH) Beta thalassemia Biliary tract cancer Bipolar disorder Bladder cancer Bladder pain syndrome Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Bleeding Bone and Cartilage Cancer Bone sarcoma Breast cancer Calciphylaxis Cancer pain Cardiovascular disease (CVD) Cardiovascular events Cardiovascular System Cervical cancer Charcot-Marie-Tooth disease Chemoradiation-induced oral mucositis Chemotherapy-induced neutropenia Chemotherapy-induced thrombocytopenia Cholangiocarcinoma Choroideremia Chronic heart failure Chronic hepatitis D Chronic kidney disease (CKD) Chronic lymphocytic leukaemia (CLL) Chronic myeloid leukaemia (CML) Chronic myelomonocytic leukaemia (CMML) Chronic obstructive pulmonary disease (COPD) Chronic spontaneous urticaria (CSU) Chronic thromboembolic pulmonary hypertension (CTEPH) Clostridioides difficile infection Cognitive impairment Cold agglutinin disease (CAD) Colon cancer Colorectal cancer Common cold Complex regional pain syndrome (CRPS) Congenital heart disease Congenital hyperinsulinism Critical limb ischaemia (CLI) Crohn's disease Cutaneous T-cell lymphoma (CTCL) Cystic fibrosis Cytomegalovirus (CMV) Delayed graft function (DGF) Dental and Oral Health Depression Dermatology Diabetic foot ulcer (DFU) Diabetic macular oedema Diabetic nephropathy Diabetic retinopathy Differentiated thyroid cancer (DTC) Diffuse large B-cell lymphoma (DLBCL) Distal renal tubular acidosis Duchenne muscular dystrophy (DMD) Dystrophic epidermolysis bullosa (DEB) Ear Endometrial cancer Endometriosis-associated pain Enthesitis-related arthritis Eosinophilic oesophagitis Epilepsy Epithelial ovarian cancer Erectile dysfunction Erythropoietic protoporphyria Exocrine pancreatic insufficiency (EPI) Fabry disease Fallopian tube cancer Familial adenomatous polyposis (FAP) Familial primary hypoalphalipoproteinemia Fatal Female Reproductive Cancer Fibrodysplasia ossificans progressiva Focal segmental glomerulosclerosis (FSGS) Follicular lymphoma Gastric cancer Gastro-oesophageal junction adenocarcinoma Gastro-oesophageal junction cancer Gastrointestinal Cancer Gastrointestinal stromal tumour (GIST) Generalised pustular psoriasis Genetic Disorders Geographic atrophy Giant cell arteritis Glaucoma Glioma Glucose transporter type 1 deficiency syndrome Graft versus host disease (GvHD) Granulomatosis with polyangiitis (GPA) Gynaecology and Obstetrics Haemophilia A Haemophilia B Hand dysfunction Head and neck cancer Heart failure (HF) Heavy menstrual bleeding Hepatocellular carcinoma (HCC) Hereditary angioedema (HAE) Heterozygous familial hypercholesterolaemia (HeFH) Hidradenitis suppurativa (HS) High grade B cell lymphoma (HGBCL) HIV infection HIV-1 infection Hodgkin lymphoma Hot flushes Huntington's disease Hyperargininemia Hypereosinophilic syndrome (HES) Hyperlipidaemia Hyperphagia Hypersomnia Hypertrophic cardiomyopathy (HCM) Hypoglycaemia Hypophosphataemia Hypoplasminogenaemia Idiopathic chronic cough Idiopathic inflammatory myopathies Idiopathic thrombocytopenic purpura IgA nephropathy Immune thrombocytopenia (ITP) Immunodeficiency Influenza Inherited epidermolysis bullosa (EB) Injured gluteal musculature Insomnia Interstitial cystitis Interstitial lung disease (ILD) Iron overload Irritable bowel syndrome with predominant constipation (IBS-C) Ischaemic stroke Juvenile idiopathic arthritis Juvenile psoriatic arthritis Leber's hereditary optic neuropathy (LHON) Lennox-Gastaut syndrome Leukocyte adhesion deficiency Long chain fatty acid oxidation disorders (LC-FAOD) Lower limb spasticity Lupus nephritis Lymphoblastic lymphoma (LBL) Lymphocytic colitis Major adverse cardiovascular events (MACE) Major cardiovascular events Major depressive disorder (MDD) Malignant pleural mesothelioma (MPM) Mantle cell lymphoma Marginal zone lymphoma (MZL) Mature T-cell lymphoma Medullary thyroid cancer (MTC) Melanoma Merkel cell carcinoma (MCC) Metabolic acidosis Metabolic Disorders Metachromatic leukodystrophy (MLD) Methotrexate toxicity during cancer therapy Microscopic polyangiitis (MPA) Migraine Mixed dyslipidaemia Motor neurone disease (MND or ALS) Mucopolysaccharidosis type IIIB (Sanfilippo B syndrome) Mucopolysaccharidosis type VII Multiple myeloma (MM) Multiple sclerosis (MS) Muscle spasticity Myasthenia gravis (MG) Myelodysplastic syndrome (MDS) Myelofibrosis Myofibroblastic tumour Myotonia Myotonic dystrophy Narcolepsy Nasal polyps Nasopharyngeal cancer Neuroblastoma Neurofibromatosis Neurogenic detrusor overactivity Neuromyelitis optica Neuromyelitis optica spectrum disorders Niemann-Pick Disease Nocturia Non-alcoholic steatohepatitis (NASH) Non-gBRCA mutated high-grade serous ovarian cancer Non-Hodgkin lymphoma (NHL) Non-malignant diseases Non-metastatic prostate cancer Non-small-cell lung cancer (NSCLC) Nose and Throat Obesity Obesity due to Leptin receptor deficiency Obesity due to pro-opiomelanocortin deficiency Ocular hypertension Ocular inflammatory pain Oesophageal cancer Oesophageal squamous cell carcinoma Opioid dependence Opioid overdose Oral ulcers Orthostatic hypotension Osteoarthritic pain Osteomalacia Osteoporosis Ovarian cancer Ovarian function Painful bladder syndrome Pancreatic cancer Parkinson's disease Paroxysmal nocturnal haemoglobinuria Paroxysmal nocturnal haemoglobinuria (PNH) Peanut allergy Pemphigus vulgaris Peripheral arterial disease (PAD) Peripheral T-cell lymphoma (PTCL) Plaque psoriasis Polycythaemia vera Pompe disease Post-acute myocardial infarction (MI) Post-menopausal vasomotor symptoms Post-operative inflammation Post-operative pain Post-transplant lymphoproliferative disease (PTLD) Postnatal depression Pouchitis Prevention of skeletal related events in multiple myeloma Primary biliary cholangitis (PBC) Primary generalised tonic-clonic seizures Primary haemophagocytic lymphohistiocytosis (HLH) Primary hypercholesterolaemia Primary hyperoxaluria Primary mediastinal large B-cell lymphoma (PMBCL) Primary open-angle glaucoma primary peritoneal cancer Primary sclerosing cholangitis (PSC) Procedural sedation Progeria Progressive familial intrahepatic cholestasis (PFIC) Progressive fibrosing interstitial lung disease (PF-ILD) Progressive supranuclear palsy (PSP) Prostate cancer Prurigo nodularis (PN) Pruritus Psoriatic arthritis Pulmonary arterial hypertension (PAH) Pyruvate kinase deficiency Regeneration of cartilage Renal anaemia Renal cell carcinoma (RCC) Respiratory dysfunction Retinopathy of prematurity Rett syndrome Rheumatoid arthritis Rhinosinusitis Schizophrenia Schnitzler syndrome Serious Trouble Short bowel syndrome Sialorrhea Sickle cell anaemia Sickle cell disease (SCD) Small lymphocytic lymphoma (SLL) Small-cell lung cancer (SCLC) Soft tissue sarcoma Solid tumours Spasmodic torticollis Spinal cord injury Spinal muscular atrophy (SMA) Spondyloarthritis Squamous cell carcinoma (SCC) Stroke Sudden sensorineural hearing loss Super-refractory status epilepticus (SRSE) Synovial sarcoma Systemic lupus erythematosus (SLE) Systemic mastocytosis Systemic sclerosis Tendon injury Tenosynovial giant cell tumour (TGCT) Thromboembolism Thyroid cancer Transthyretin amyloid cardiomyopathy Traumatic brain injury (TBI) Tree pollen allergy Tuberous sclerosis Type 1 diabetes Type 2 diabetes Ulcerative colitis Ulcerative proctitis Uncontrolled bleeding Urinary incontinence Urothelial cancer Uveal melanoma Venous leg ulcers Visual impairment Vitiligo Weight management WHIM syndrome Wilson's disease Wiskott-Aldrich syndrome (WAS) X-linked adrenoleukodystrophy (X-ALD) X-linked protoporphyria Check All
By clicking "subscribe" I confirm that I am happy to receive alerts.
Subscribed successfully.